Severe Prolonged Immunosuppression following Fludarabine and Rituximab Combination Therapy

Publisher： Karger

E-ISSN： 1421-9794|54|3|242-244

ISSN： 0009-3157

Source： Chemotherapy, Vol.54, Iss.3, 2008-06, pp. : 242-244

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Severe Pulmonary Toxicity Associated with Fludarabine and Possible Contribution of Rituximab

By  

Chemotherapy, Vol. 56, Iss. 2, 2010-03 ,pp. : 89-93

Karger

Access to resources Recommend Favorite

Systems Analysis of Drug-Induced Receptor Tyrosine Kinase Reprogramming Following Targeted Mono- and Combination Anti-Cancer Therapy

By Goltsov Alexey   Deeni Yusuf   Khalil Hilal S.   Soininen Tero   Kyriakidis Stylianos   Hu Huizhong   Langdon Simon P.   Harrison David J.   Bown James  

Cells, Vol. 3, Iss. 2, 2014-06 ,pp. : 563-591

MDPI

Access to resources Recommend Favorite

A Case of Pulmonary Lymphomatoid Granulomatosis Successfully Treated by Combination Chemotherapy with Rituximab

By  

Chemotherapy, Vol. 55, Iss. 5, 2009-09 ,pp. : 386-390

Karger

Access to resources Recommend Favorite

Combination Therapy with Olmesartan and Amlodipine in the Treatment of Hypertension

By Niemeijer Menco G.   Cleophas Ton J.  

Pharmaceuticals, Vol. 2, Iss. 3, 2009-12 ,pp. : 125-133

MDPI

Access to resources Recommend Favorite

Enhancing Photodynamyc Therapy Efficacy by Combination Therapy: Dated, Current and Oncoming Strategies

By Postiglione Ilaria   Chiaviello Angela   Palumbo Giuseppe  

Cancers, Vol. 3, Iss. 2, 2011-06 ,pp. : 2597-2629

MDPI

Access to resources Recommend Favorite